-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Balchem Co. (NASDAQ:BCPC) Stock Position Lessened by Metropolitan Life Insurance Co NY
Balchem Co. (NASDAQ:BCPC) Stock Position Lessened by Metropolitan Life Insurance Co NY
Metropolitan Life Insurance Co NY reduced its stake in shares of Balchem Co. (NASDAQ:BCPC – Get Rating) by 75.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,011 shares of the basic materials company's stock after selling 6,209 shares during the quarter. Metropolitan Life Insurance Co NY's holdings in Balchem were worth $275,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of BCPC. Intelligent Financial Strategies acquired a new position in Balchem during the 4th quarter valued at about $25,000. UMB Bank N A MO bought a new position in shares of Balchem in the fourth quarter valued at approximately $56,000. Carolinas Wealth Consulting LLC increased its stake in shares of Balchem by 130.5% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 484 shares of the basic materials company's stock valued at $82,000 after acquiring an additional 274 shares during the period. First Horizon Advisors Inc. raised its holdings in Balchem by 43.1% during the fourth quarter. First Horizon Advisors Inc. now owns 558 shares of the basic materials company's stock worth $93,000 after purchasing an additional 168 shares in the last quarter. Finally, Destiny Wealth Partners LLC boosted its stake in Balchem by 58.4% during the 1st quarter. Destiny Wealth Partners LLC now owns 659 shares of the basic materials company's stock valued at $90,000 after purchasing an additional 243 shares in the last quarter. Institutional investors and hedge funds own 89.15% of the company's stock.
Get Balchem alerts:Balchem Stock Up 3.1 %
Shares of Balchem stock opened at $134.35 on Thursday. Balchem Co. has a 12-month low of $110.15 and a 12-month high of $174.29. The firm has a market capitalization of $4.32 billion, a PE ratio of 40.22 and a beta of 0.59. The company has a quick ratio of 1.64, a current ratio of 2.62 and a debt-to-equity ratio of 0.50. The stock's fifty day moving average is $131.75 and its 200-day moving average is $129.99.
Insider Buying and Selling
In other Balchem news, VP Gunsteren Job Leonard Van sold 3,601 shares of the company's stock in a transaction dated Wednesday, August 3rd. The shares were sold at an average price of $125.62, for a total transaction of $452,357.62. Following the completion of the sale, the vice president now directly owns 1,430 shares of the company's stock, valued at $179,636.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is currently owned by company insiders.Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on BCPC shares. HC Wainwright upped their price objective on Balchem from $152.00 to $164.00 and gave the company a "buy" rating in a report on Monday, August 22nd. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a research report on Monday, August 1st.
Balchem Profile
(Get Rating)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
See Also
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Get Rating).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.
Metropolitan Life Insurance Co NY reduced its stake in shares of Balchem Co. (NASDAQ:BCPC – Get Rating) by 75.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,011 shares of the basic materials company's stock after selling 6,209 shares during the quarter. Metropolitan Life Insurance Co NY's holdings in Balchem were worth $275,000 at the end of the most recent reporting period.
纽约大都会人寿保险有限公司(Metropolitan Life Insurance Co NY)在最近一次向美国证券交易委员会(Securities&Exchange Commission)披露的信息中称，该公司今年第一季度减持了75.5%的纳斯达克股票。该机构投资者在本季度出售了6,209股后，持有这家基础材料公司的2,011股股票。在最近一次报告期结束时，纽约大都会人寿保险公司在Balchem持有的股份价值27.5万美元。
Several other institutional investors have also bought and sold shares of BCPC. Intelligent Financial Strategies acquired a new position in Balchem during the 4th quarter valued at about $25,000. UMB Bank N A MO bought a new position in shares of Balchem in the fourth quarter valued at approximately $56,000. Carolinas Wealth Consulting LLC increased its stake in shares of Balchem by 130.5% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 484 shares of the basic materials company's stock valued at $82,000 after acquiring an additional 274 shares during the period. First Horizon Advisors Inc. raised its holdings in Balchem by 43.1% during the fourth quarter. First Horizon Advisors Inc. now owns 558 shares of the basic materials company's stock worth $93,000 after purchasing an additional 168 shares in the last quarter. Finally, Destiny Wealth Partners LLC boosted its stake in Balchem by 58.4% during the 1st quarter. Destiny Wealth Partners LLC now owns 659 shares of the basic materials company's stock valued at $90,000 after purchasing an additional 243 shares in the last quarter. Institutional investors and hedge funds own 89.15% of the company's stock.
其他几家机构投资者也买卖了BCPC的股票。智能财务战略公司在第四季度收购了Balchem的一个新头寸，价值约为25,000美元。UMB Bank N A MO在第四季度购买了Balchem的新头寸，价值约56,000美元。Carolinas Wealth Consulting LLC在第四季度增持了Balchem的股份130.5%。Carolinas Wealth Consulting LLC现在拥有这家基础材料公司484股股票，价值82,000美元，在此期间又购买了274股。First Horizon Advisors Inc.在第四季度增持了43.1%的Balchem股份。First Horizon Advisors Inc.现在持有这家基础材料公司558股股票，价值93,000美元，该公司在上个季度又购买了168股。最后，Destiny Wealth Partners LLC在第一季度将其在Balchem的持股增加了58.4%。Destination Wealth Partners LLC现在持有这家基础材料公司659股股票，价值9万美元，上个季度又购买了243股。机构投资者和对冲基金持有该公司89.15%的股票。
Balchem Stock Up 3.1 %
Balchem股票上涨3.1%
Shares of Balchem stock opened at $134.35 on Thursday. Balchem Co. has a 12-month low of $110.15 and a 12-month high of $174.29. The firm has a market capitalization of $4.32 billion, a PE ratio of 40.22 and a beta of 0.59. The company has a quick ratio of 1.64, a current ratio of 2.62 and a debt-to-equity ratio of 0.50. The stock's fifty day moving average is $131.75 and its 200-day moving average is $129.99.
周四，Balchem的股票开盘报134.35美元。Balchem Co.的股价为110.15美元，为12个月低点，12个月高位为174.29美元。该公司市值为43.2亿美元，市盈率为40.22倍，贝塔系数为0.59。该公司的速动比率为1.64，流动比率为2.62，债务权益比率为0.50。该股的50日移动均线切入位为131.75美元，200日移动均线切入位为129.99美元。
Insider Buying and Selling
内幕买卖
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
Several analysts have recently weighed in on BCPC shares. HC Wainwright upped their price objective on Balchem from $152.00 to $164.00 and gave the company a "buy" rating in a report on Monday, August 22nd. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a research report on Monday, August 1st.
几位分析师最近纷纷买入BCPC的股票。在8月22日周一的一份报告中，HC Wainwright将Balchem的目标价从152.00美元上调至164.00美元，并给予该公司“买入”评级。在8月1日星期一的一份研究报告中，StockNews.com将Balchem的股票评级从“买入”下调至“持有”。
Balchem Profile
Balchem配置文件
(Get Rating)
(获取评级)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem公司为美国和国际的营养、食品、制药、动物保健、医疗器械消毒、植物营养和工业市场开发、制造和销售特殊性能成分和产品。它通过三个部分运作：人类营养与健康，动物营养与健康，以及特色产品。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- 3 High Margin Chipmakers Bound to Recover
- 3 Solar Stocks That Will Benefit From the Biden Tariff Holiday
- REV Group Has A Deep Moat In The World Of EVs
- Is G-III Apparel Group, Ltd. A Value Trap?
- Bank Of America Sees Upside In These 2 European Alcohol Stocks
- 免费获取StockNews.com关于Balchem的研究报告(BCPC)
- 3家高利润率芯片制造商势必复苏
- 将受益于拜登关税假期的3只太阳能股
- REV集团在电动汽车世界拥有深厚的护城河
- G-III服装集团有限公司是价值陷阱吗？
- 美国银行看好这两只欧洲酒类股票
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Get Rating).
想看看其他对冲基金持有BCPC的情况吗？访问HoldingsChannel.com获取Balchem Co.(纳斯达克代码：BCPC-GET Rating)的最新13F备案文件和内幕交易信息。
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.
接受Balchem Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Balchem和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧